Across TCGA pan-cancer cohorts, ANKRD20A8P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of ANKRD20A8P’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where ANKRD20A8P RNA is repressed in tumor relative to normal tissue. In most cancer types ANKRD20A8P is over-expressed in tumor, although a few such as THCA and KICH show the opposite, repressed pattern.

THCA, KICH, and PAAD are the cancer types where ANKRD20A8P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ANKRD20A8P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	III,IV	−0.311	<.001	9	view →
KICH	All	All	−0.010	.018	4	view →
PAAD	All	All	−0.034	.015	2	view →
COAD	Male	All	−0.006	.012	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: ANKRD20A8P RNA expression & survival · all ANKRD20A8P data types